vs
Side-by-side financial comparison of Organon & Co. (OGN) and RENAISSANCERE HOLDINGS LTD (RNR). Click either name above to swap in a different company.
RENAISSANCERE HOLDINGS LTD is the larger business by last-quarter revenue ($2.2B vs $1.5B, roughly 1.5× Organon & Co.). RENAISSANCERE HOLDINGS LTD runs the higher net margin — 23.5% vs -13.6%, a 37.1% gap on every dollar of revenue. On growth, Organon & Co. posted the faster year-over-year revenue change (-5.3% vs -36.8%). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -11.9%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
RenaissanceRe Holdings Ltd is a Bermudian provider of reinsurance, insurance and other related business services. The company operates in reinsurance, insurance and ventures.
OGN vs RNR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $2.2B |
| Net Profit | $-205.0M | $515.8M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | — |
| Net Margin | -13.6% | 23.5% |
| Revenue YoY | -5.3% | -36.8% |
| Net Profit YoY | -288.1% | 72.6% |
| EPS (diluted) | $-0.78 | $6.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.5B | $3.0B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.6B | $3.2B | ||
| Q1 25 | $1.5B | $3.5B | ||
| Q4 24 | $1.6B | $2.3B | ||
| Q3 24 | $1.6B | $4.0B | ||
| Q2 24 | $1.6B | $2.8B |
| Q1 26 | — | $515.8M | ||
| Q4 25 | $-205.0M | $760.5M | ||
| Q3 25 | $160.0M | $916.5M | ||
| Q2 25 | $145.0M | $835.4M | ||
| Q1 25 | $87.0M | $170.0M | ||
| Q4 24 | $109.0M | $-189.7M | ||
| Q3 24 | $359.0M | $1.2B | ||
| Q2 24 | $195.0M | $503.9M |
| Q1 26 | — | — | ||
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.8% | 42.5% | ||
| Q3 25 | 15.2% | 46.3% | ||
| Q2 25 | 14.4% | 41.8% | ||
| Q1 25 | 6.7% | -2.0% | ||
| Q4 24 | 8.1% | -3.6% | ||
| Q3 24 | 13.1% | 43.7% | ||
| Q2 24 | 14.6% | 25.0% |
| Q1 26 | — | 23.5% | ||
| Q4 25 | -13.6% | 25.6% | ||
| Q3 25 | 10.0% | 28.7% | ||
| Q2 25 | 9.1% | 26.1% | ||
| Q1 25 | 5.8% | 4.9% | ||
| Q4 24 | 6.8% | -8.3% | ||
| Q3 24 | 22.7% | 29.8% | ||
| Q2 24 | 12.1% | 17.8% |
| Q1 26 | — | $6.57 | ||
| Q4 25 | $-0.78 | $16.16 | ||
| Q3 25 | $0.61 | $19.40 | ||
| Q2 25 | $0.56 | $17.20 | ||
| Q1 25 | $0.33 | $3.27 | ||
| Q4 24 | $0.42 | $-3.76 | ||
| Q3 24 | $1.38 | $22.62 | ||
| Q2 24 | $0.75 | $9.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $1.6B |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $4.3B |
| Total Assets | $12.9B | $53.7B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.6B | ||
| Q4 25 | $574.0M | $1.7B | ||
| Q3 25 | $672.0M | $1.7B | ||
| Q2 25 | $599.0M | $1.4B | ||
| Q1 25 | $547.0M | $1.6B | ||
| Q4 24 | $675.0M | $1.7B | ||
| Q3 24 | $763.0M | $1.6B | ||
| Q2 24 | $704.0M | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | $8.6B | $2.3B | ||
| Q3 25 | $8.8B | $2.2B | ||
| Q2 25 | $8.9B | $2.3B | ||
| Q1 25 | $9.0B | $2.8B | ||
| Q4 24 | $8.9B | $1.9B | ||
| Q3 24 | $8.7B | $1.9B | ||
| Q2 24 | $8.7B | $2.0B |
| Q1 26 | — | $4.3B | ||
| Q4 25 | $752.0M | $11.6B | ||
| Q3 25 | $906.0M | $11.5B | ||
| Q2 25 | $733.0M | $10.8B | ||
| Q1 25 | $542.0M | $10.3B | ||
| Q4 24 | $472.0M | $10.6B | ||
| Q3 24 | $493.0M | $11.2B | ||
| Q2 24 | $144.0M | $10.2B |
| Q1 26 | — | $53.7B | ||
| Q4 25 | $12.9B | $53.8B | ||
| Q3 25 | $13.6B | $54.5B | ||
| Q2 25 | $13.5B | $54.7B | ||
| Q1 25 | $13.2B | $53.6B | ||
| Q4 24 | $13.1B | $50.7B | ||
| Q3 24 | $12.8B | $52.8B | ||
| Q2 24 | $12.2B | $51.6B |
| Q1 26 | — | — | ||
| Q4 25 | 11.49× | 0.20× | ||
| Q3 25 | 9.74× | 0.19× | ||
| Q2 25 | 12.14× | 0.21× | ||
| Q1 25 | 16.52× | 0.27× | ||
| Q4 24 | 18.81× | 0.18× | ||
| Q3 24 | 17.75× | 0.17× | ||
| Q2 24 | 60.11× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | — |
| Free Cash FlowOCF − Capex | $96.0M | — |
| FCF MarginFCF / Revenue | 6.4% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $141.0M | $483.0M | ||
| Q3 25 | $264.0M | $1.6B | ||
| Q2 25 | $220.0M | $1.5B | ||
| Q1 25 | $75.0M | $157.8M | ||
| Q4 24 | $390.0M | $778.9M | ||
| Q3 24 | $141.0M | $1.5B | ||
| Q2 24 | $332.0M | $1.2B |
| Q1 26 | — | — | ||
| Q4 25 | $96.0M | — | ||
| Q3 25 | $218.0M | — | ||
| Q2 25 | $181.0M | — | ||
| Q1 25 | $43.0M | — | ||
| Q4 24 | $335.0M | — | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $300.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.4% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 18.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.64× | ||
| Q3 25 | 1.65× | 1.73× | ||
| Q2 25 | 1.52× | 1.76× | ||
| Q1 25 | 0.86× | 0.93× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 0.39× | 1.26× | ||
| Q2 24 | 1.70× | 2.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
